<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="via its corticostriatal projection, possibly depending on the level of" exact="dopamine" post="receptor activation (or lack of) in the ventral tegmental"/>
 <result pre="output to the PAG [ 45]. As with opioid receptors," exact="dopamine" post="D2-like receptor activation could attenuate the inhibitory action of"/>
 <result pre="to the PAG [ 46, 47]. Microinjection of a non-selective" exact="dopamine" post="receptor agonist, apomorphine, or the dopamine D2 receptor (D2R)"/>
 <result pre="Microinjection of a non-selective dopamine receptor agonist, apomorphine, or the" exact="dopamine" post="D2 receptor (D2R) agonist, quinpirole, into the VLO attenuates"/>
 <result pre="of D2R in the PFC [ 48]. Endogenous release of" exact="dopamine" post="in the rat PFC, induced by high-frequency stimulation of"/>
 <result pre="and this effect is reversed by the opioid receptor antagonist" exact="naloxone" post="[ 44]. In another study, the VLO is found"/>
 <result pre="of chronic pain, possibly as a result of changes in" exact="dopamine" post="and opioid systems that play a role in endogenous"/>
 <result pre="in the midbrain [ 17]. Close appositions are found between" exact="dopamine" post="fibers and GABAergic interneurons in the ACC [ 82]."/>
 <result pre="GABAergic interneurons in the ACC [ 82]. In addition, the" exact="dopamine" post="D2/D3 receptor availability in the ventrolateral PFC has been"/>
 <result pre="correlate with recalled efficacy of placebo, suggesting a role of" exact="dopamine" post="in pain processing [ 83]. In animals, high-frequency stimulation"/>
 <result pre="impairs the long-lasting suppression evoked by high-frequency stimulation, suggesting that" exact="dopamine" post="may modify PFC nociceptive responses via the D2R ["/>
 <result pre="IL-1β, TNF-α, and 8-OH-dG) in the PFC[ 127]. Daily intrathecal" exact="minocycline" post="treatment to reduce microglial activation starting from POD0 for"/>
 <result pre="regions, with disease progression [ 206]. A reduction in brain" exact="dopamine" post="signaling due to compensatory downregulation of dopamine receptors could"/>
 <result pre="reduction in brain dopamine signaling due to compensatory downregulation of" exact="dopamine" post="receptors could also occur as a result of addiction."/>
 <result pre="and could lead to increased corticostriatal input. The release of" exact="dopamine" post="via the VTA-projection is a key part of the"/>
 <result pre="show depressed intracranial-self stimulation and extracellular levels of nucleus accumbens" exact="dopamine" post="[ 210]. It has been suggested that changes in"/>
 <result pre="Based on this possibility, we postulate that one function of" exact="dopamine" post="D2 receptors in the nucleus accumbens is to counteract"/>
 <result pre="(2) depending on chronic neuroinflammatory processes, and the level of" exact="dopamine" post="receptor activation (or lack of) in the VTA-nucleus accumbens"/>
 <result pre="gyrus, DLPFC, and precentral gyrus [ 248]. In another study," exact="naloxone" post="injection significantly decreased the analgesic effects of M1 stimulation,"/>
 <result pre="M1 or DLPFC rTMS are also decreased by ketamine. Since" exact="ketamine" post="is an inhibitor of NMDA receptors, this suggests that"/>
 <result pre="inhibitor antidepressants including duloxetine, tricyclic antidepressants such as amitriptyline, capsaicin," exact="lidocaine" post="patches, tramadol, botulinum toxin, and opioids. Rectal pain induces"/>
 <result pre="cortex, but only during stress [ 265]. In another study," exact="duloxetine" post="treatment is associated with a significant reduction in brain"/>
 <result pre="pain scores during treatment with milnacipran, a selective serotonin and" exact="norepinephrine" post="reuptake inhibitor (SNRI), in fibromyalgia patients are correlated with"/>
 <result pre="of neuroinflammation [ 268]. Treatment of rats with tapentadol, a" exact="norepinephrine" post="reuptake inhibitor with μ-opioid receptor agonistic activity, has recently"/>
 <result pre="severe pain, which results in a dose-dependent increase in cortical" exact="dopamine" post="and norepinephrine levels with a mean maximum increase of"/>
 <result pre="which results in a dose-dependent increase in cortical dopamine and" exact="norepinephrine" post="levels with a mean maximum increase of 600 and"/>
 <result pre="Izawa Y Abe H Kawakami Y Amygdala-prefrontal pathways and the" exact="dopamine" post="system affect nociceptive responses in the prefrontal cortex BMC"/>
 <result pre="Huo FQ Du JQ Tang JS D2-like but not D1-like" exact="dopamine" post="receptors are involved in the ventrolateral orbital cortex-induced antinociception:"/>
 <result pre="FQ Tang JS Qu CL Chen T The role of" exact="dopamine" post="receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat"/>
 <result pre="49. Sogabe S Yagasaki Y Onozawa K Kawakami Y Mesocortical" exact="dopamine" post="system modulates mechanical nociceptive responses recorded in the rat"/>
 <result pre="al. Placebo analgesia: self-report measures and preliminary evidence of cortical" exact="dopamine" post="release associated with placebo response Neuroimage Clin 2016 10"/>
 <result pre="et al. A selective alpha2 B adrenoceptor agonist (A-1262543) and" exact="duloxetine" post="modulate nociceptive neurones in the medial prefrontal cortex, but"/>
 <result pre="traits determine the differential neuroinflammatory responses and analgesic effect of" exact="minocycline" post="in chronic neuropathic pain Brain Behav Immun 2016 58"/>
 <result pre="Jr Banks ML Negus SS Pain-related depression of the mesolimbic" exact="dopamine" post="system in rats: expression, blockade by analgesics, and role"/>
 <result pre="Soriano-Mas C Deus J Ortiz H et al. Effects of" exact="duloxetine" post="treatment on brain response to painful stimulation in major"/>
 <result pre="268. Burke NN Finn DP Roche M Chronic administration of" exact="amitriptyline" post="differentially alters neuropathic pain-related behaviour in the presence and"/>
 <result pre="G Irappanavar S Ponnamaneni R Manoharan A Mechanistic evaluation of" exact="tapentadol" post="in reducing the pain perception using in-vivo brain and"/>
 <result pre="Lee SW Lee S Cho IH et al. Effects of" exact="tianeptine" post="on symptoms of fibromyalgia via BDNF signaling in a"/>
 <result pre="prefrontal cortical calcium independent phospholipase A(2) in antidepressant-like effect of" exact="maprotiline" post="Int J Neuropsychopharmacol 2012 15 8 1087 1098 10.1017/S1461145711001234"/>
 <result pre="prefrontal cortical calcium-independent phospholipase A2 in antinociceptive effect of the" exact="norepinephrine" post="reuptake inhibitor antidepresssant maprotiline Neuroscience 2017 340 91 100"/>
 <result pre="A2 in antinociceptive effect of the norepinephrine reuptake inhibitor antidepresssant" exact="maprotiline" post="Neuroscience 2017 340 91 100 10.1016/j.neuroscience.2016.10.037 27789386 273. Li"/>
 <result pre="contribute to depression-like phenotype after spared nerve injury: improvement by" exact="ketamine" post="Sci Rep 2017 7 1 3124 10.1038/s41598-017-03590-3 28600519 305."/>
 <result pre="Manhaes A Schmidt S Attentional performance may help to identify" exact="duloxetine" post="responders in chronic pain fibromyalgia patients Eur J Pain"/>
</results>
